Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
about
Hepatocellular carcinoma: Where are we?Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining IssuesRecent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRIHepatocellular carcinoma: early-stage management challengesGadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis.MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis.Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.Association between relative liver enhancement on gadoxetic acid enhanced magnetic resonance images and histologic grade of hepatocellular carcinoma.Limited detection of small (≤ 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection.The Effect of New Therapeutic and Diagnostic Agents on the Prognosis of Hepatocellular Carcinoma in Japan – An Analysis of Data from the Kanagawa Cancer RegistryCritical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.Management of subcentimetre arterially enhancing and hepatobiliary hypointense lesions on gadoxetic acid-enhanced MRI in patients at risk for HCC.Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency Ablation.Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey.
P2860
Q26765182-B8F7A21E-1250-4CE8-910E-7800700B18B5Q26770020-A06CD55B-6D7B-4C90-8CF1-8909962CC5A7Q28075361-69F52C92-4CF5-4271-B335-3F1FF862981CQ33881131-13C5811C-6BD0-4602-8920-62E84F068453Q36051492-BAC22F01-67BD-46E3-AC15-8ABCB18CEA92Q38387249-D472278F-FE5F-4E7E-9C5D-CEF2F4F75228Q39016627-54799B16-F95D-4039-BF5C-AEA3F0E7CF70Q40886924-4BAA3F93-5261-4B02-A2EA-B84956E82719Q41997513-50DDD259-85E6-49CB-B518-5F813CD7BD93Q47103572-70058038-CE34-4B3A-92B6-4EC9FE6A780DQ47156791-02790F91-50FC-4A58-87EC-F6B8060299D7Q47566919-CEB27053-ABE9-407B-ABDB-AD1C09CFB3DCQ48622310-EB8C9A7C-8C6D-4C58-9C7E-40D637DE19BCQ49884601-80B36506-70D9-43BE-8DF8-62DECF999752Q50215520-03661EBD-B7B5-4B63-B71D-5216BF5214E1
P2860
Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluation of early-stage hepa ...... nd increases overall survival.
@en
type
label
Evaluation of early-stage hepa ...... nd increases overall survival.
@en
prefLabel
Evaluation of early-stage hepa ...... nd increases overall survival.
@en
P2093
P1433
P1476
Evaluation of early-stage hepa ...... and increases overall survival
@en
P2093
Hyung Jin Won
Hyung-Don Kim
Jae Ho Byun
Seungbong Han
So Jung Lee
So Yeon Kim
Young-Suk Lim
P304
P356
10.1053/J.GASTRO.2015.02.051
P407
P50
P577
2015-02-28T00:00:00Z